Skip to main content

Novartis Top Menu

  • Novartis.com
Home

User account menu

  • Search
  • Menu
  • About Us
    • Board of Trustees
      • Joerg Reinhardt, Ph.D.
      • Ann Aerts, M.D.
      • Dr. Jo Ivey Boufford
      • Lutz Hegemann, M.D., Ph.D.
      • Prof. Peter Piot, M.D.
    • Our Team
      • Johannes Boch
      • Cristina Haffner
      • Jason Shellaby
      • Lucy Setian
      • Sarah Des Rosiers
      • Xavier Sutter
    • Our partners
    About Us
  • Transforming population health
    • Cardiovascular population health initiative
    • AI4BetterHearts
    • AI in health policy
      • Broadband Commission Working Group on Digital and AI in Health
      • HealthTech Dialogue Hub
    • HealthTech Innovation
      • Brazil COVID-19 response
      • AI4Leprosy
    Transforming Population Health
  • Urban Population Health Toolkit
    • Cardio Approach
    Urban Population Health Toolkit
  • Past programs
    • Better Hearts Better Cities
      • Community-based Hypertension Improvement Project (ComHIP)
      • Communities for Healthy Hearts
      • KaziBantu (Healthy Schools for Healthy Communities)
    • Leprosy and malaria elimination
      • The Leprosy Alert and Response Network System (LEARNS)
      • Leprosy Post-Exposure Prophylaxis (LPEP) program
      • Malaria Targeted Parasite Elimination Strategy
    • Digital Health
      • Ghana Telemedicine
      • Telemedicine Toolkit
      • Integrated e-Diagnostic Approach
    Past Programs
  • Media Center
    • News Archive
    • Media Library
    • Stories
    Media Center
Homepage
  1. Home
  2. Media Center
  3. Media Library

Innovative Tools and Approaches to End the Transmission of Mycobacterium Leprae

Back to Previous Page

The drive to interrupt M leprae transmission and finally eliminate leprosy is entering a crucial stage. Sustainability, perseverance, and constant innovation will be crucial to the success of a programme to halt transmission of M leprae.

Download (PDF 144.79 KB)

Related Items

Leprosy, Publication
Leprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme
Document
Leprosy, Publication
Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective
Document
Leprosy, Publication
An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia
Document
Leprosy, Publication
Minimal Essential Data to Document Contact Tracing and Single Dose Rifampicin (SDR) for Leprosy Control in Routine Settings: A Practical Guide
Document

Novartis Foundation

This block is broken or missing. You may be missing content or you might need to enable the original module.

Navigate Novartis Foundation

  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs

About the Novartis Foundation

  • Board of Trustees
  • Our Partners
  • Our Team

Media Center

  • News Archive
  • Media Library
  • Our Stories

Footer Bottom

© 2021 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Site Map
This site is intended for a global audience